Ginkgo Bioworks Holdings (DNA) EBIT Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 0.00% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 16.22% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -40.32% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 19.73% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 104.48% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -0.66% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 22.39% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -198,288.76% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.66% |
| Mar 31, 2026 | 11.85% |
| Dec 31, 2025 | 31.71% |
| Sep 30, 2025 | -63.06% |
| Jun 30, 2025 | 73.91% |
| Mar 31, 2025 | 54.51% |
| Dec 31, 2024 | 41.83% |
| Sep 30, 2024 | 80.72% |
| Jun 30, 2024 | -21.07% |
| Mar 31, 2024 | 17.49% |
| Dec 31, 2023 | 22.85% |
| Sep 30, 2023 | 56.27% |
| Jun 30, 2023 | 71.57% |
| Mar 31, 2023 | 68.06% |
| Dec 31, 2022 | 86.30% |
| Sep 30, 2022 | -2,355.53% |
| Jun 30, 2022 | -980.62% |
| Mar 31, 2022 | -1,082.48% |
| Dec 31, 2021 | -2,914.48% |
| Sep 30, 2021 | 22.49% |